Story perspectives

Real-World Data Revolutionizes Clinical Trials, Boosts Recruitment

9/22/2025

31 4

Summary

Story summary

Real-world data (RWD) improves clinical trial recruitment by offering insights into diverse patient populations.
Oncology is the leading field for RWD use, with 34% of studies employing these data.
China represents 30% of global RWD trials, followed by Italy, Germany, the U.S., and Japan.
Combining RWD with machine learning (ML) enhances patient identification and recruitment efficiency.
Datavant and Indegene's partnership aims to boost recruitment for rare diseases, minimizing screen failures and speeding up enrollment.

1 of 1

Story summary

Real-world data (RWD) improves clinical trial recruitment by offering insights into diverse patient populations.
Oncology is the leading field for RWD use, with 34% of studies employing these data.
China represents 30% of global RWD trials, followed by Italy, Germany, the U.S., and Japan.
Combining RWD with machine learning (ML) enhances patient identification and recruitment efficiency.
Datavant and Indegene's partnership aims to boost recruitment for rare diseases, minimizing screen failures and speeding up enrollment.